Schnell O - Search Results

1

Self-monitoring of blood glucose in type 2 diabetes: recent studies.

Schnell O, Alawi H, Battelino T, Ceriello A, Diem P, Felton AM, Grzeszczak W, Harno K, Kempler P, Satman I, Vergès B. Schnell O, et al. J Diabetes Sci Technol. 2013 Mar 1;7(2):478-88. doi: 10.1177/193229681300700225. J Diabetes Sci Technol. 2013. PMID: 23567007 Free PMC article. Review.

2

High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM.

Schnell O, Eisfelder B, Standl E, Ziegler AG. Schnell O, et al. Diabetes. 1997 Oct;46(10):1607-11. doi: 10.2337/diacare.46.10.1607. Diabetes. 1997. PMID: 9313757 Clinical Trial.

3

Exposure to exogenous insulin promotes IgG1 and the T-helper 2-associated IgG4 responses to insulin but not to other islet autoantigens.

Füchtenbusch M, Kredel K, Bonifacio E, Schnell O, Ziegler AG. Füchtenbusch M, et al. Among authors: schnell o. Diabetes. 2000 Jun;49(6):918-25. doi: 10.2337/diabetes.49.6.918. Diabetes. 2000. PMID: 10866043 Clinical Trial.

4

[Diagnosis of acute myocardial infarction in diabetes mellitus. Blood sugar to be tested].

Schnell O, Otter W. Schnell O, et al. MMW Fortschr Med. 2003 May 22;145(21):35-8. MMW Fortschr Med. 2003. PMID: 12845865 German.

5

The links between diabetes and cardiovascular disease.

Schnell O. Schnell O. J Interv Cardiol. 2005 Dec;18(6):413-6. doi: 10.1111/j.1540-8183.2005.00080.x. J Interv Cardiol. 2005. PMID: 16336420 Free article. Review.

6

Impaired glucose tolerance, diabetes, and cardiovascular disease.

Schnell O, Standl E. Schnell O, et al. Endocr Pract. 2006 Jan-Feb;12 Suppl 1:16-9. doi: 10.4158/EP.12.S1.16. Endocr Pract. 2006. PMID: 16627374 Review.

7

Acarbose and metabolic control in patients with type 2 diabetes with newly initiated insulin therapy.

Schnell O, Mertes G, Standl E; Acarbose-Insulin Combination Study Group. Schnell O, et al. Diabetes Obes Metab. 2007 Nov;9(6):853-8. doi: 10.1111/j.1463-1326.2006.00666.x. Diabetes Obes Metab. 2007. PMID: 17924867 Clinical Trial.

8

The impact of glucose-lowering therapy on cardiovascular outcomes.

Standl E, Müller M, Schnell O. Standl E, et al. Among authors: schnell o. Best Pract Res Clin Endocrinol Metab. 2009 Jun;23(3):401-11. doi: 10.1016/j.beem.2009.03.010. Best Pract Res Clin Endocrinol Metab. 2009. PMID: 19520312 Review.

9

Consensus report of the coalition for clinical research-self-monitoring of blood glucose.

Klonoff DC, Bergenstal R, Blonde L, Boren SA, Church TS, Gaffaney J, Jovanovic L, Kendall DM, Kollman C, Kovatchev BP, Leippert C, Owens DR, Polonsky WH, Reach G, Renard E, Riddell MC, Rubin RR, Schnell O, Siminiero LM, Vigersky RA, Wilson DM, Wollitzer AO. Klonoff DC, et al. Among authors: schnell o. J Diabetes Sci Technol. 2008 Nov;2(6):1030-53. doi: 10.1177/193229680800200612. J Diabetes Sci Technol. 2008. PMID: 19885292 Free PMC article.

10

Postprandial hyperglycemia and glycemic variability: should we care?

Standl E, Schnell O, Ceriello A. Standl E, et al. Among authors: schnell o. Diabetes Care. 2011 May;34 Suppl 2(Suppl 2):S120-7. doi: 10.2337/dc11-s206. Diabetes Care. 2011. PMID: 21525442 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

316 results

Search Page